TBY talks to Gopal Vasu, CEO, M&G Pharmaceuticals, on the sector.

Gopal Vasu

What have been the major highlights for the company since its founding, and what is your growth strategy?

The company was established in 1993. We started with only four products and 11 employees on our payroll; today, M&G is producing about 78 different products for about 800 customers, which include the Ministry of Health, Ghana Health Service, private hospitals, mission hospitals, pharmacies, chemical sellers, and more. We definitely have a plan to expand the pharma business because lots of goods are coming into Ghana from global funding. We are in the process of relocating our unit so that we can implement WHO good manufacturing practices and eventually obtain pre-qualification. Today, among ECOWAS countries, Ghana, Nigeria, and Ivory Coast are the only ones with a solid pharmaceutical or industrial base; most of the francophone countries do not have a good industrial base. We see that as an opportunity and are trying to expand our business into those markets.